Laverty joins Eisai
Prior to joining Novartis, Laverty worked in several corporate policy, corporate affairs, and product public affairs positions at Bristol-Myers Squibb Company.
There's a reason pharma lags on the programmatic adoption curve: It's a heavily regulated industry, and there are concerns around privacy.
Where are the discussions about applying proven behavior change models or the principles of adult learning and health literacy?
Such intense interest in health content is a rich opportunity to engage, inform, support, and motivate key customer constituencies.